Asymchem is a CMO/CDMO company operating in the pharmaceutical industry.
A USFDA-inspected CDMO experienced in developing sustainable processes for late phase to commercial small molecule and peptide APIs with a proven track record of taking projects from development to commercial scale.
Founded in 1995, Asymchem has 7 sites across P.R. China and an enabling technology platform in continuous flow and biocatalysis, with a specialized facility for the development and GMP manufacture of HPAPI.
Capabilities and experience in hazardous chemistry applications includes ozonolysis, hydrogenation, and other high temperature and high-pressure reactions. Asymchem has a research group dedicated to process optimization, process design space characterization (PAR/NOR), and manufacturing of peptides and peptide-containing drugs.
Company type
CMO/CDMO
Products and services
Custom Manufacturing, Excipients, Intermediates, Fine and Specialty Chemicals, APIs (Active Pharmaceutical Ingredients), Pharmaceutical Machinery & Technology
Markets
North America (USA, Canada), East Asia (e.g. China, Japan, Korea), Europe – EU countries, South America (e.g. Brazil, Colombia)
Useful Links
Connect with Asymchem on LinkedIn
Address
Asymchem, 600 Airport Blvd,, Morrisville, NC, United States, 2756
